Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 18 January 2027
- Last conf. stmt
- 4 January 2026
Regenold United Kingdom Ltd
- Incorporated
- 7 January 2011 (15 years)
- Previously known as
- Jensonr+ Limited (until 7 May 2026)Jensonukr+ Limited (until 11 February 2011)This list may be incomplete. See all names on Companies House
- Industry
- Other professional, scientific and technical activities n.e.c. (74909)
- Directors
- Paul QuinnBernd Schuler
- Owned by
- Accounts type
- Full
- Region
- South West
- Address
- Fishleigh CourtFishleigh RoadBarnstapleEX31 3UD
Charges
- Total
- 2
- Outstanding
- 0
- Part satisfied
- 0
- Satisfied
- 2
Officers 3 active
Officer details are public data from the Companies House register.
Director · Appointed 1 May 2026
British
Born May 1968 (58)
Quinn, Paul
Director · Appointed 30 November 2025
Irish
Born August 1978 (48)
Schuler, Bernd
Director · Appointed 22 November 2023
Austrian
Born August 1968 (58)
Officer history (9 former)
1 May 2026
30 November 2025
Appointed Quinn, Paul as Director
30 November 2025
30 November 2025
30 October 2025
1 April 2025
22 November 2023
Appointed Schuler, Bernd as Director
22 November 2023
Resigned Regenold, Luisa as Director
23 March 2023
15 February 2023
Appointed Regenold, Luisa as Director
15 February 2023
31 October 2022
1 March 2022
28 February 2022
Resigned Schnirring-Mayer, Jutta as Director
24 May 2016
7 September 2015
7 September 2015
7 September 2015
7 January 2011
7 January 2011
Appointed Schnirring-Mayer, Jutta as Director
7 January 2011
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 13 October 2017
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Limited
Reg. no. 10971822
Former controllers (1)
13 October 2017
Group structure 4 companies
Ownership group derived from the Companies House PSC register
Nextec Medical UK Ltd Owns 75–100% of shares
Regenold United Kingdom Ltd This company Owns 75–100% of shares
Taw Pharma Limited Owns 75–100% of shares
Financials
Figures from 2024 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Net Assets
- £939,158
- Cash
- £447,429
- Profit
- £656,553
- Employees
- 42
- Debt Ratio
- 47%
- Current Ratio
- 2.1x
- Return on Equity
- 70%
Trend
Net Assets
Balance sheet detail
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Fixed Assets | £69,547 | £299,821 | £354,757 | £375,315 | £420,222 | £325,111 |
| Current Assets | £1,701,624 | £1,256,773 | £1,837,449 | £1,736,419 | £1,107,032 | £1,164,117 |
| Debtors | £1,254,195 | £857,900 | £699,531 | £973,854 | £530,419 | £688,965 |
| Cash | £447,429 | £398,873 | £1,128,869 | £753,748 | £507,588 | £468,973 |
| Creditors (< 1 year) | £815,013 | £685,716 | £869,754 | £908,336 | £794,675 | £625,190 |
| Creditors (> 1 year) | £0 | £81,168 | £92,031 | £111,679 | ||
| Net Current Assets | £886,611 | £571,057 | £967,695 | £828,083 | £312,357 | £538,927 |
| Net Assets | £939,158 | £782,605 | £979,207 | £847,364 | £699,769 | £732,052 |
| Shareholder Funds | £939,158 | £782,605 | £979,207 | £847,364 | £699,769 | £732,052 |
Filings
Filing history not loaded yet. See it on Companies House
Some other companies at this address
Other companies in this industry
Cambridge
Normanton
Hessle
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →